Literature DB >> 11049786

Wound botulism in California, 1951-1998: recent epidemic in heroin injectors.

S B Werner1, D Passaro, J McGee, R Schechter, D J Vugia.   

Abstract

California has reported most of the world's wound botulism (WB) cases and nearly three-fourths of the cases reported in the United States. We reviewed the clinical, epidemiologic, and laboratory features of WB. From the first case in 1951, through 1998, a total of 127 cases were identified-93 in the last 5 years. The dramatic increase has been due to an epidemic (of WB) in people who inject black tar heroin. Whereas early cases of WB occurred after gross trauma, all but 1 of the last 102 cases occurred in drug users, primarily those who inject drugs subcutaneously ("skin poppers"). Cases are occurring disproportionately in Hispanics and women. Misdiagnosis and diagnostic delays of up to 64 days have occurred. This unprecedented, ongoing epidemic is now being reported in other states. We discuss the clinical and laboratory features that distinguish botulism from conditions that can mimic it, the relative yield of various diagnostic laboratory tests for botulism, and its treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11049786     DOI: 10.1086/318134

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

1.  Wound botulism associated with subcutaneous drug use.

Authors:  A F A Merrison; K E Chidley; J Dunnett; K A Sieradzan
Journal:  BMJ       Date:  2002-11-02

2.  Botulism as a cause of respiratory failure in injecting drug users.

Authors:  S FitzGerald; R Lyons; J Ryan; W Hall; C Gallagher
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

3.  Skin and Soft Tissue Infections in Injection Drug Users.

Authors:  Patricia D. Brown; John R. Ebright
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 4.  Clostridial neurotoxins.

Authors:  A Goonetilleke; J B Harris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

5.  Wound botulism in drug users: a still underestimated diagnosis.

Authors:  C Rodolico; E Barca; L Fenicia; F Anniballi; A U Sinardi; P Girlanda
Journal:  Neurol Sci       Date:  2010-06-15       Impact factor: 3.307

6.  Wound botulism from heroin skin popping.

Authors:  Larry E Davis; Molly K King
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

7.  Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Authors:  Dongxia Wang; Jakub Baudys; Yiming Ye; Jon C Rees; John R Barr; James L Pirkle; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2012-09-24       Impact factor: 3.365

8.  Wound botulism complicating internal fixation of a complex radial fracture.

Authors:  Steve M Taylor; Cameron R Wolfe; Terry C Dixon; David S Ruch; Gary M Cox
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

9.  Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Bioorg Med Chem       Date:  2015-04-10       Impact factor: 3.641

10.  Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Authors:  Dongxia Wang; Joan Krilich; Sabine Pellett; Jakub Baudys; William H Tepp; John R Barr; Eric A Johnson; Suzanne R Kalb
Journal:  Biochim Biophys Acta       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.